Resverlogix Corp. announced the appointment of Dr. Ewelina Kulikowski, Ph.D. as Chief Scientific Officer. Dr. Norman Wong is retiring as CSO, effective August 15, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | 0.00% |
|
-9.09% | -28.57% |
May. 15 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Resverlogix Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-28.57% | 10.11M | |
+21.17% | 127B | |
+23.94% | 116B | |
+25.15% | 27.69B | |
-19.34% | 19.62B | |
-16.57% | 16.26B | |
-15.82% | 15.49B | |
+11.61% | 14.81B | |
-46.65% | 14.39B | |
+57.45% | 14.11B |
- Stock Market
- Equities
- RVX Stock
- News Resverlogix Corp.
- Resverlogix Corp. Announces Management Changes